Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(21%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_4
2
14%
Ph phase_3
3
21%
Ph phase_1
7
50%

Phase Distribution

7

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
7(58.3%)
Phase 3Large-scale testing
3(25.0%)
Phase 4Post-market surveillance
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(11)

Detailed Status

Completed11
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (58.3%)
Phase 33 (25.0%)
Phase 42 (16.7%)

Trials by Status

recruiting214%
active_not_recruiting17%
completed1179%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07136415Phase 4

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Recruiting
NCT07028697Phase 3

A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

Completed
NCT06498128

Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

Recruiting
NCT06393504

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Active Not Recruiting
NCT05597020Phase 4

A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

Completed
NCT06010693Phase 3

A Study of Daridorexant in Chinese Patients With Insomnia Disorder

Completed
NCT06326723Phase 1

Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects

Completed
NCT05632393Phase 1

A Study to Measure Daridorexant in Breast Milk of Healthy Lactating Women

Completed
NCT05458193Phase 1

A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep

Completed
NCT05480488Phase 1

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male Subjects

Completed
NCT05480475Phase 1

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects

Completed
NCT03575104Phase 3

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Completed
NCT04390334Phase 1

A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.

Completed
NCT04250506Phase 1

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14